MBBS, MD (NYU), Fellow (Heme & MedOnc USA), MS (Columbia Univ, USA) Diplomate American Board – Internal Medicine, Haematology & Medical Oncology
Dr Sewanti Limaye came to Kokilaben Hospital from Columbia University Medical Center/New York Presbyterian Hospital, New York-USA where she worked as an Attending in Medical Oncology and Assistant Professor of Medicine. She specialises in the treatment of all solid tumours including breast, lung, head and neck, GI, GU and gynaecologic cancers. In addition to giving chemotherapy, she has specific expertise in cancer genomics, targeted therapy and cutting-edge treatment with immunotherapy. She is board certified in internal medicine, haematology and medical oncology and has been practising as a medical oncologist since the year 2009.
Dr Limaye received her medical degree with honours from Jawahar Lal Nehru Medical College, Bhagalpur and did her residency in Internal Medicine from NY Downtown Hospital - New York University. She did her fellowship in Haematology and Medical Oncology from Albert Einstein University, North Shore-Long Island Jewish Medical Center, New York. She was nominated to serve as the Chief Fellow in the final year of her fellowship. After completing her fellowship, she went on to work as an Attending in Medical Oncology at the Dana Farber Cancer Institute/Brigham and Women's Hospital and at the Phase I - Early Drug Development Center - Harvard Medical School in Boston, USA. She also did a Masters in Patient Oriented Research (Cancer Genomics and Biostatistics) from Mailman School of Public Health, Columbia University, New York. She has also worked as an Attending at Columbia University Medical Center in the Medical Oncology division where she practised cancer genomics, chemotherapy, targeted therapy and cutting-edge treatment with immunotherapy.
She has been involved in research with leaders at Memorial Sloan Kettering Cancer Center, Dana Farber Cancer Institute, Columbia University Medical Center and National Cancer Institute, USA. She has led several national and international trials and has been a part of Data Safety Monitoring Boards.
Dr Limaye is committed to the development of novel therapeutics in solid tumours.
Hindi, English, Marathi
ATTENTION: YOU ARE NOW LEAVING THE RELIANCE HOSPITALS WEBSITE. PLEASE CAREFULLY READ THE NOTICE BELOW BEFORE PROCEEDING.
By clicking "continue" below, you acknowledge that any images, text, video or other content viewed henceforth were not created by Reliance Hospital. Neither Reliance Hospital or any of its affiliates are responsible for this content.
If you do not understand or acknowledge the aforementioned, please click "back" to return to Reliance Hospital website.